TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs29232
log Bayes Factor = 16.2202
Chromosome 6   position 29,611,431  (GRCh37) Explore rs29232 on Ensembl!
Variant rs29232 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
K90.0 Coeliac disease
0.000 0.000 1.000
E03.9 Hypothyroidism, unspecified
0.000 0.011 0.989
E03 Other hypothyroidism
0.000 0.054 0.946
E00-E07 Disorders of thyroid gland
0.000 0.087 0.913
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.089 0.911
E05.9 Thyrotoxicosis, unspecified
0.000 0.092 0.908
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.130 0.870
L40.9 Psoriasis, unspecified
0.770 0.230 0.000
E03.8 Other specified hypothyroidism
0.000 0.245 0.755
L40 Psoriasis
0.716 0.284 0.000
L40.5 Arthropathic psoriasis
0.679 0.321 0.000
E03.5 Myxoedema coma
0.000 0.322 0.678
E03.4 Atrophy of thyroid (acquired)
0.000 0.322 0.678
E03.3 Postinfectious hypothyroidism
0.000 0.322 0.678
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.322 0.678
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.346 0.654
E00 Congenital iodine-deficiency syndrome
0.000 0.346 0.654
E05.5 Thyroid crisis or storm
0.000 0.347 0.653
E05.4 Thyrotoxicosis factitia
0.000 0.347 0.653
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.347 0.653
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.347 0.653
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.350 0.650
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.360 0.640
E03.1 Congenital hypothyroidism without goitre
0.000 0.362 0.638
L40.0 Psoriasis vulgaris
0.621 0.379 0.000
L40.8 Other psoriasis
0.600 0.399 0.000
E05.8 Other thyrotoxicosis
0.000 0.425 0.575
E06 Thyroiditis
0.000 0.434 0.566
K90 Intestinal malabsorption
0.000 0.438 0.562
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.444 0.556
E83.1 Disorders of iron metabolism
0.000 0.461 0.539
E10 Insulin-dependent diabetes mellitus
0.000 0.461 0.539
E10-E14 Diabetes mellitus
0.000 0.465 0.535
L40.2 Acrodermatitis continua
0.513 0.487 0.000
E70-E90 Metabolic disorders
0.000 0.496 0.504
E83 Disorders of mineral metabolism
0.000 0.499 0.501
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.499 0.501
L40.4 Guttate psoriasis
0.496 0.504 0.000
E10.2 With renal complications
0.000 0.510 0.490
E10.3 With ophthalmic complications
0.000 0.511 0.489
E89.0 Postprocedural hypothyroidism
0.000 0.520 0.480
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.000 0.521 0.479
E89.2 Postprocedural hypoparathyroidism
0.000 0.522 0.478
E10.5 With peripheral circulatory complications
0.000 0.530 0.470
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.531 0.469
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.531 0.469
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.531 0.469
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.531 0.469
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.531 0.469
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.531 0.469
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.531 0.469
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.531 0.469
L40.1 Generalised pustular psoriasis
0.467 0.533 0.000
L40.3 Pustulosis palmaris et plantaris
0.466 0.534 0.000
E06.3 Autoimmune thyroiditis
0.000 0.538 0.462
E10.8 With unspecified complications
0.000 0.554 0.446
K90.9 Intestinal malabsorption, unspecified
0.000 0.555 0.445
E10.4 With neurological complications
0.000 0.559 0.441
E10.6 With other specified complications
0.000 0.567 0.433
E10.1 With ketoacidosis
0.000 0.574 0.426
E07 Other disorders of thyroid
0.000 0.583 0.417
E06.4 Drug-induced thyroiditis
0.000 0.594 0.406
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.594 0.406
E06.0 Acute thyroiditis
0.000 0.594 0.406
E89.3 Postprocedural hypopituitarism
0.000 0.596 0.404
K90.3 Pancreatic steatorrhoea
0.000 0.597 0.403
K90.2 Blind loop syndrome, not elsewhere classified
0.000 0.597 0.403
K90.1 Tropical sprue
0.000 0.597 0.403
E10.0 With coma
0.000 0.609 0.391
E79 Disorders of purine and pyrimidine metabolism
0.000 0.613 0.387
E10.7 With multiple complications
0.000 0.614 0.386
E12 Malnutrition-related diabetes mellitus
0.000 0.616 0.383
E73 Lactose intolerance
0.000 0.621 0.379
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.626 0.374
E85 Amyloidosis
0.000 0.634 0.366
E06.5 Other chronic thyroiditis
0.000 0.636 0.363
E10.9 Without complications
0.000 0.638 0.362
E77 Disorders of glycoprotein metabolism
0.000 0.639 0.361
E76 Disorders of glycosaminoglycan metabolism
0.000 0.639 0.361
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.639 0.361
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.639 0.361
E06.9 Thyroiditis, unspecified
0.000 0.639 0.360
E83.8 Other disorders of mineral metabolism
0.000 0.641 0.359
E83.2 Disorders of zinc metabolism
0.000 0.641 0.359
E83.0 Disorders of copper metabolism
0.000 0.641 0.359
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.641 0.359
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.641 0.359
E89.5 Postprocedural testicular hypofunction
0.000 0.641 0.359
E89.1 Postprocedural hypoinsulinaemia
0.000 0.641 0.359
E65-E68 Obesity and other hyperalimentation
0.000 0.644 0.356
E84 Cystic fibrosis
0.000 0.645 0.355
E70 Disorders of aromatic amino-acid metabolism
0.000 0.653 0.346
E13 Other specified diabetes mellitus
0.000 0.657 0.342
E72 Other disorders of amino-acid metabolism
0.000 0.660 0.340
E06.1 Subacute thyroiditis
0.000 0.670 0.330
E83.9 Disorder of mineral metabolism, unspecified
0.000 0.672 0.328
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.672 0.328
E89.4 Postprocedural ovarian failure
0.000 0.672 0.327
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.001 0.680 0.319
E04 Other non-toxic goitre
0.000 0.685 0.315
K90.8 Other intestinal malabsorption
0.000 0.686 0.314
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.688 0.312
E74 Other disorders of carbohydrate metabolism
0.000 0.691 0.309
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.696 0.304
E07.1 Dyshormogenetic goitre
0.000 0.701 0.299
E07.0 Hypersecretion of calcitonin
0.000 0.701 0.299
E40-E46 Malnutrition
0.000 0.706 0.294
E85.3 Secondary systemic amyloidosis
0.000 0.706 0.293
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.707 0.293
E73.9 Lactose intolerance, unspecified
0.000 0.710 0.290
E20-E35 Disorders of other endocrine glands
0.000 0.712 0.288
E14 Unspecified diabetes mellitus
0.000 0.712 0.288
E27 Other disorders of adrenal gland
0.000 0.716 0.284
E27.1 Primary adrenocortical insufficiency
0.000 0.719 0.281
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.722 0.278
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.722 0.278
E79.1 Lesch-Nyhan syndrome
0.000 0.722 0.278
E12.9 Without complications
0.000 0.725 0.275
E12.8 With unspecified complications
0.000 0.725 0.275
E12.7 With multiple complications
0.000 0.725 0.275
E12.6 With other specified complications
0.000 0.725 0.275
E12.5 With peripheral circulatory complications
0.000 0.725 0.275
E12.4 With neurological complications
0.000 0.725 0.275
E12.3 With ophthalmic complications
0.000 0.725 0.275
E12.2 With renal complications
0.000 0.725 0.275
E12.1 With ketoacidosis
0.000 0.725 0.275
E12.0 With coma
0.000 0.725 0.275
E85.4 Organ-limited amyloidosis
0.000 0.725 0.275
E73.8 Other lactose intolerance
0.000 0.728 0.272
E73.1 Secondary lactase deficiency
0.000 0.728 0.272
E73.0 Congenital lactase deficiency
0.000 0.728 0.272
E07.8 Other specified disorders of thyroid
0.000 0.729 0.270
E84.9 Cystic fibrosis, unspecified
0.000 0.730 0.270
E15 Nondiabetic hypoglycaemic coma
0.000 0.732 0.268
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.738 0.262
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.738 0.262
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.738 0.262
E71.3 Disorders of fatty-acid metabolism
0.000 0.741 0.259
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.741 0.259
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.741 0.259
E71.0 Maple-syrup-urine disease
0.000 0.741 0.259
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.741 0.259
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.741 0.259
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.741 0.259
E76.2 Other mucopolysaccharidoses
0.000 0.741 0.259
E76.1 Mucopolysaccharidosis, type II
0.000 0.741 0.259
E76.0 Mucopolysaccharidosis, type I
0.000 0.741 0.259
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.741 0.259
E77.8 Other disorders of glycoprotein metabolism
0.000 0.741 0.259
E77.1 Defects in glycoprotein degradation
0.000 0.741 0.259
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.741 0.259
E85.8 Other amyloidosis
0.000 0.742 0.258
E04.0 Non-toxic diffuse goitre
0.000 0.743 0.257
E65 Localised adiposity
0.000 0.744 0.256
E67 Other hyperalimentation
0.000 0.745 0.255
E68 Sequelae of hyperalimentation
0.000 0.745 0.255
E14.3 With ophthalmic complications
0.000 0.745 0.255
E84.8 Cystic fibrosis with other manifestations
0.000 0.745 0.254
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.745 0.254
E83.4 Disorders of magnesium metabolism
0.000 0.746 0.254
E13.3 With ophthalmic complications
0.000 0.746 0.254
E83.3 Disorders of phosphorus metabolism
0.000 0.750 0.250
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.751 0.248
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.751 0.248
E70.2 Disorders of tyrosine metabolism
0.000 0.751 0.248
E70.1 Other hyperphenylalaninaemias
0.000 0.751 0.248
E70.0 Classical phenylketonuria
0.000 0.751 0.248
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.753 0.247
E13.8 With unspecified complications
0.000 0.754 0.246
E13.7 With multiple complications
0.000 0.754 0.246
E13.6 With other specified complications
0.000 0.754 0.246
E13.5 With peripheral circulatory complications
0.000 0.754 0.246
E13.4 With neurological complications
0.000 0.754 0.246
E13.2 With renal complications
0.000 0.754 0.246
E13.1 With ketoacidosis
0.000 0.754 0.246
E13.0 With coma
0.000 0.754 0.246
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.756 0.244
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.756 0.244
E72.5 Disorders of glycine metabolism
0.000 0.756 0.244
E72.4 Disorders of ornithine metabolism
0.000 0.756 0.244
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.756 0.244
E72.2 Disorders of urea cycle metabolism
0.000 0.756 0.244
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.756 0.244
E16 Other disorders of pancreatic internal secretion
0.000 0.756 0.244
E75.6 Lipid storage disorder, unspecified
0.000 0.765 0.235
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.765 0.235
E75.3 Sphingolipidosis, unspecified
0.000 0.765 0.235
E75.1 Other gangliosidosis
0.000 0.765 0.235
E75.0 GM2 gangliosidosis
0.000 0.765 0.235
E70.3 Albinism
0.000 0.766 0.234
E14.6 With other specified complications
0.000 0.767 0.233
E80.2 Other porphyria
0.000 0.767 0.233
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.771 0.229
E80.1 Porphyria cutanea tarda
0.000 0.772 0.228
L40-L45 Papulosquamous disorders
0.226 0.773 0.001
E14.8 With unspecified complications
0.000 0.774 0.226
E04.8 Other specified non-toxic goitre
0.000 0.774 0.226
E75.5 Other lipid storage disorders
0.000 0.776 0.224
E72.0 Disorders of amino-acid transport
0.000 0.777 0.223
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.778 0.222
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.778 0.222
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.778 0.222
E74.2 Disorders of galactose metabolism
0.000 0.778 0.222
E74.1 Disorders of fructose metabolism
0.000 0.778 0.222
E74.0 Glycogen storage disease
0.000 0.778 0.222
E75.2 Other sphingolipidosis
0.000 0.785 0.215
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.785 0.215
E14.1 With ketoacidosis
0.000 0.787 0.213
E85.9 Amyloidosis, unspecified
0.000 0.788 0.211
E44 Protein-energy malnutrition of moderate and mild degree
0.000 0.789 0.211
E45 Retarded development following protein-energy malnutrition
0.000 0.789 0.211
E43 Unspecified severe protein-energy malnutrition
0.000 0.789 0.211
E42 Marasmic kwashiorkor
0.000 0.789 0.211
E41 Nutritional marasmus
0.000 0.789 0.211
E40 Kwashiorkor
0.000 0.789 0.211
E66 Obesity
0.000 0.789 0.211
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.790 0.210
E80.5 Crigler-Najjar syndrome
0.000 0.790 0.210
E80.3 Defects of catalase and peroxydase
0.000 0.790 0.210
E80.0 Hereditary erythropoietic porphyria
0.000 0.790 0.210
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.793 0.207
E32 Diseases of thymus
0.000 0.793 0.207
E31 Polyglandular dysfunction
0.000 0.793 0.207
E30 Disorders of puberty, not elsewhere classified
0.000 0.793 0.207
E14.7 With multiple complications
0.000 0.794 0.206
E14.0 With coma
0.000 0.794 0.206
E27.5 Adrenomedullary hyperfunction
0.000 0.796 0.203
E27.0 Other adrenocortical overactivity
0.000 0.796 0.203
E20 Hypoparathyroidism
0.000 0.802 0.198
E27.2 Addisonian crisis
0.000 0.803 0.197
E23 Hypofunction and other disorders of pituitary gland
0.000 0.804 0.196
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.804 0.196
E25 Adrenogenital disorders
0.000 0.805 0.195
E29 Testicular dysfunction
0.000 0.808 0.192
E13.9 Without complications
0.000 0.808 0.192
E66.8 Other obesity
0.000 0.811 0.189
E28 Ovarian dysfunction
0.000 0.812 0.188
E34 Other endocrine disorders
0.000 0.812 0.188
E50-E64 Other nutritional deficiencies
0.000 0.813 0.187
E67.8 Other specified hyperalimentation
0.000 0.817 0.183
E67.3 Hypervitaminosis D
0.000 0.817 0.183
E67.2 Megavitamin-B6 syndrome
0.000 0.817 0.183
E67.1 Hypercarotenaemia
0.000 0.817 0.183
E67.0 Hypervitaminosis A
0.000 0.817 0.183
E24 Cushing's syndrome
0.000 0.819 0.181
E88 Other metabolic disorders
0.001 0.821 0.179
E27.8 Other specified disorders of adrenal gland
0.000 0.824 0.176
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.825 0.175
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.825 0.175
E16.4 Abnormal secretion of gastrin
0.000 0.825 0.175
E16.3 Increased secretion of glucagon
0.000 0.825 0.175
L42 Pityriasis rosea
0.173 0.826 0.001
E14.5 With peripheral circulatory complications
0.000 0.830 0.170
E74.3 Other disorders of intestinal carbohydrate absorption
0.000 0.830 0.169
L44 Other papulosquamous disorders
0.167 0.832 0.001
E14.2 Withrenal complications
0.000 0.836 0.164
L41 Parapsoriasis
0.162 0.837 0.001
L45 Papulosquamous disorders in diseases classified elsewhere
0.162 0.837 0.001
E14.4 With neurological complications
0.000 0.839 0.161
E27.9 Disorder of adrenal gland, unspecified
0.000 0.846 0.154
E26 Hyperaldosteronism
0.000 0.846 0.153
E23.6 Other disorders of pituitary gland
0.000 0.847 0.153
E80.6 Other disorders of bilirubin metabolism
0.000 0.847 0.152
E04.1 Non-toxic single thyroid nodule
0.000 0.848 0.152
E44.1 Mild protein-energy malnutrition
0.000 0.848 0.151
E44.0 Moderate protein-energy malnutrition
0.000 0.848 0.151
E66.1 Drug-induced obesity
0.000 0.848 0.151
E22 Hyperfunction of pituitary gland
0.000 0.851 0.149
E30.9 Disorder of puberty, unspecified
0.000 0.851 0.148
E30.8 Other disorders of puberty
0.000 0.851 0.148
E30.1 Precocious puberty
0.000 0.851 0.148
E30.0 Delayed puberty
0.000 0.851 0.148
E31.9 Polyglandular dysfunction, unspecified
0.000 0.851 0.148
E31.8 Other polyglandular dysfunction
0.000 0.851 0.148
E31.1 Polyglandular hyperfunction
0.000 0.851 0.148
E31.0 Autoimmune polyglandular failure
0.000 0.851 0.148
E32.9 Disease of thymus, unspecified
0.000 0.851 0.148
E32.8 Other diseases of thymus
0.000 0.851 0.148
E32.1 Abscess of thymus
0.000 0.851 0.148
E32.0 Persistent hyperplasia of thymus
0.000 0.851 0.148
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.851 0.148
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.851 0.148
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.851 0.148
E16.1 Other hypoglycaemia
0.000 0.851 0.148
E16.2 Hypoglycaemia, unspecified
0.000 0.854 0.146
E04.2 Non-toxic multinodular goitre
0.000 0.855 0.145
E23.7 Disorder of pituitary gland, unspecified
0.000 0.856 0.144
E28.3 Primary ovarian failure
0.000 0.856 0.144
E53 Deficiency of other B group vitamins
0.000 0.856 0.144
E20.8 Other hypoparathyroidism
0.000 0.857 0.142
E20.1 Pseudohypoparathyroidism
0.000 0.857 0.142
E20.0 Idiopathic hypoparathyroidism
0.000 0.857 0.142
E34.8 Other specified endocrine disorders
0.000 0.858 0.142
E66.2 Extreme obesity with alveolar hypoventilation
0.000 0.859 0.141
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.859 0.141
E23.1 Drug-induced hypopituitarism
0.000 0.859 0.141
E80.4 Gilbert's syndrome
0.000 0.860 0.140
E25.9 Adrenogenital disorder, unspecified
0.000 0.860 0.140
E25.8 Other adrenogenital disorders
0.000 0.860 0.140
E29.8 Other testicular dysfunction
0.000 0.862 0.138
E29.0 Testicular hyperfunction
0.000 0.862 0.138
K51.9 Ulcerative colitis, unspecified
0.000 0.863 0.137
E28.9 Ovarian dysfunction, unspecified
0.000 0.865 0.135
E28.8 Other ovarian dysfunction
0.000 0.865 0.135
E28.1 Androgen excess
0.000 0.865 0.135
E28.0 Oestrogen excess
0.000 0.865 0.135
E88.9 Metabolic disorder, unspecified
0.000 0.865 0.134
E34.5 Androgen resistance syndrome
0.000 0.865 0.135
E34.4 Constitutional tall stature
0.000 0.865 0.135
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.865 0.135
E34.1 Other hypersecretion of intestinal hormones
0.000 0.865 0.135
E64 Sequelae of malnutrition and other nutritional deficiencies
0.000 0.866 0.134
E63 Other nutritional deficiencies
0.000 0.866 0.134
E51 Thiamine deficiency
0.000 0.866 0.134
E50 Vitamin A deficiency
0.000 0.866 0.134
E60 Dietary zinc deficiency
0.000 0.866 0.134
E59 Dietary selenium deficiency
0.000 0.866 0.134
E52 Niacin deficiency [pellagra]
0.000 0.866 0.134
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.866 0.134
E29.9 Testicular dysfunction, unspecified
0.000 0.866 0.134
E20.9 Hypoparathyroidism, unspecified
0.000 0.866 0.134
E34.0 Carcinoid syndrome
0.000 0.867 0.133
E88.8 Other specified metabolic disorders
0.000 0.869 0.131
E66.0 Obesity due to excess calories
0.000 0.869 0.130
E24.8 Other Cushing's syndrome
0.000 0.870 0.130
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.870 0.130
E24.3 Ectopic ACTH syndrome
0.000 0.870 0.130
E24.1 Nelson's syndrome
0.000 0.870 0.130
E07.9 Disorder of thyroid, unspecified
0.000 0.870 0.129
E34.3 Short stature, not elsewhere classified
0.000 0.871 0.129
E54 Ascorbic acid deficiency
0.000 0.872 0.128
E29.1 Testicular hypofunction
0.000 0.872 0.128
E23.2 Diabetes insipidus
0.000 0.872 0.128
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.872 0.127
E04.9 Non-toxic goitre, unspecified
0.000 0.873 0.127
E88.3 Tumour lysis syndrome
0.001 0.874 0.126
L44.0 Pityriasis rubra pilaris
0.125 0.874 0.001
E24.0 Pituitary-dependent Cushing's disease
0.000 0.876 0.124
E24.9 Cushing's syndrome, unspecified
0.000 0.877 0.123
E23.0 Hypopituitarism
0.000 0.877 0.123
E56 Other vitamin deficiencies
0.001 0.878 0.121
L44.9 Papulosquamous disorder, unspecified
0.120 0.879 0.001
L44.8 Other specified papulosquamous disorders
0.120 0.879 0.001
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]
0.120 0.879 0.001
L44.3 Lichen ruber moniliformis
0.120 0.879 0.001
L44.2 Lichen striatus
0.120 0.879 0.001
L44.1 Lichen nitidus
0.120 0.879 0.001
E24.2 Drug-induced Cushing's syndrome
0.000 0.880 0.120
E53.9 Vitamin B deficiency, unspecified
0.000 0.881 0.119
L41.9 Parapsoriasis, unspecified
0.116 0.883 0.001
L41.8 Other parapsoriasis
0.116 0.883 0.001
L41.5 Retiform parapsoriasis
0.116 0.883 0.001
L41.4 Large plaque parapsoriasis
0.116 0.883 0.001
L41.3 Small plaque parapsoriasis
0.116 0.883 0.001
L41.2 Lymphomatoid papulosis
0.116 0.883 0.001
L41.1 Pityriasis lichenoides chronica
0.116 0.883 0.001
L41.0 Pityriasis lichenoides et varioliformis acuta
0.116 0.883 0.001
E55 Vitamin D deficiency
0.000 0.884 0.116
E34.9 Endocrine disorder, unspecified
0.000 0.885 0.115
E58 Dietary calcium deficiency
0.001 0.887 0.112
E26.9 Hyperaldosteronism, unspecified
0.000 0.890 0.110
E26.8 Other hyperaldosteronism
0.000 0.890 0.110
E26.1 Secondary hyperaldosteronism
0.000 0.890 0.110
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.893 0.107
E22.8 Other hyperfunction of pituitary gland
0.000 0.893 0.107
E46 Unspecified protein-energy malnutrition
0.000 0.893 0.106
E22.1 Hyperprolactinaemia
0.000 0.895 0.105
E53.1 Pyridoxine deficiency
0.000 0.897 0.103
E53.0 Riboflavin deficiency
0.000 0.897 0.103
E28.2 Polycystic ovarian syndrome
0.000 0.897 0.102
L43 Lichen planus
0.097 0.902 0.002
E83.5 Disorders of calcium metabolism
0.000 0.902 0.098
E50.9 Vitamin A deficiency, unspecified
0.000 0.903 0.096
E50.8 Other manifestations of vitamin A deficiency
0.000 0.903 0.096
E50.7 Other ocular manifestations of vitamin A deficiency
0.000 0.903 0.096
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.000 0.903 0.096
E50.5 Vitamin A deficiency with night blindness
0.000 0.903 0.096
E50.4 Vitamin A deficiency with keratomalacia
0.000 0.903 0.096
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.000 0.903 0.096
E50.2 Vitamin A deficiency with corneal xerosis
0.000 0.903 0.096
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.000 0.903 0.096
E50.0 Vitamin A deficiency with conjunctival xerosis
0.000 0.903 0.096
E51.9 Thiamine deficiency, unspecified
0.000 0.903 0.096
E51.8 Other manifestations of thiamine deficiency
0.000 0.903 0.096
E51.2 Wernicke's encephalopathy
0.000 0.903 0.096
E51.1 Beriberi
0.000 0.903 0.096
E63.9 Nutritional deficiency, unspecified
0.000 0.903 0.096
E63.8 Other specified nutritional deficiencies
0.000 0.903 0.096
E63.1 Imbalance of constituents of food intake
0.000 0.903 0.096
E63.0 Essential fatty acid [EFA] deficiency
0.000 0.903 0.096
E64.9 Sequelae of unspecified nutritional deficiency
0.000 0.903 0.096
E64.8 Sequelae of other nutritional deficiencies
0.000 0.903 0.096
E64.3 Sequelae of rickets
0.000 0.903 0.096
E64.2 Sequelae of vitamin C deficiency
0.000 0.903 0.096
E64.1 Sequelae of vitamin A deficiency
0.000 0.903 0.096
E64.0 Sequelae of protein-energy malnutrition
0.000 0.903 0.096
L03.0 Cellulitis of finger and toe
0.000 0.905 0.095
E53.8 Deficiency of other specified B group vitamins
0.000 0.907 0.092
K51 Ulcerative colitis
0.000 0.908 0.092
E56.9 Vitamin deficiency, unspecified
0.001 0.912 0.087
E56.8 Deficiency of other vitamins
0.001 0.912 0.087
E56.0 Deficiency of vitamin E
0.001 0.912 0.087
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.913 0.087
E22.0 Acromegaly and pituitary gigantism
0.000 0.915 0.085
K51.8 Other ulcerative colitis
0.000 0.916 0.084
E55.0 Rickets, active
0.000 0.916 0.083
K51.5 Mucosal proctocolitis
0.000 0.918 0.082
E56.1 Deficiency of vitamin K
0.001 0.925 0.074
L43.3 Subacute (active) lichen planus
0.069 0.929 0.001
L43.2 Lichenoid drug reaction
0.069 0.929 0.001
L43.1 Bullous lichen planus
0.069 0.929 0.001
L43.0 Hypertrophic lichen planus
0.069 0.929 0.001
L43.8 Other lichen planus
0.069 0.930 0.001
K51.4 Pseudopolyposis of colon
0.000 0.931 0.069
E88.2 Lipomatosis, not elsewhere classified
0.001 0.933 0.066
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.067 0.933 0.000
E55.9 Vitamin D deficiency, unspecified
0.000 0.934 0.066
T36-T50 Poisoning by drugs, medicaments and biological substances
0.064 0.936 0.000
T43.2 Other and unspecified antidepressants
0.063 0.937 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.063 0.937 0.000
E61 Deficiency of other nutrient elements
0.001 0.937 0.062
K51.0 Ulcerative (chronic) enterocolitis
0.000 0.938 0.062
T43.6 Psychostimulants with abuse potential
0.061 0.938 0.000
T46.1 Calcium-channel blockers
0.061 0.939 0.000
K51.1 Ulcerative (chronic) ileocolitis
0.000 0.940 0.060
T43.3 Phenothiazine antipsychotics and neuroleptics
0.059 0.941 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.059 0.941 0.000
E26.0 Primary hyperaldosteronism
0.001 0.943 0.056
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.056 0.944 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.056 0.944 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.056 0.944 0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.054 0.946 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.054 0.946 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.054 0.946 0.000
K51.3 Ulcerative (chronic) rectosigmoiditis
0.000 0.946 0.054
T45.0 Antiallergic and antiemetic drugs
0.052 0.948 0.000
K51.2 Ulcerative (chronic) proctitis
0.000 0.948 0.052
T36 Poisoning by systemic antibiotics
0.051 0.949 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.050 0.950 0.000
T43.9 Psychotropic drug, unspecified
0.049 0.951 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.048 0.951 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.048 0.952 0.000
N28.1 Cyst of kidney, acquired
0.048 0.952 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.048 0.952 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.047 0.953 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.047 0.953 0.000
T45.2 Vitamins, not elsewhere classified
0.047 0.953 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.046 0.954 0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.046 0.954 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.046 0.954 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.045 0.954 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.045 0.954 0.000
T46.7 Peripheral vasodilators
0.045 0.954 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.045 0.954 0.000
E61.9 Deficiency of nutrient element, unspecified
0.001 0.954 0.044
E61.8 Deficiency of other specified nutrient elements
0.001 0.954 0.044
E61.7 Deficiency of multiple nutrient elements
0.001 0.954 0.044
E61.6 Vanadium deficiency
0.001 0.954 0.044
E61.5 Molybdenum deficiency
0.001 0.954 0.044
E61.4 Chromium deficiency
0.001 0.954 0.044
E61.3 Manganese deficiency
0.001 0.954 0.044
E61.0 Copper deficiency
0.001 0.954 0.044
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.045 0.955 0.000
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.001 0.955 0.045
T46.3 Coronary vasodilators, not elsewhere classified
0.045 0.955 0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.955 0.045
E86 Volume depletion
0.000 0.955 0.045
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.044 0.955 0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.956 0.044
T47.1 Other antacids and anti-gastric-secretion drugs
0.043 0.957 0.000
T47.2 Stimulant laxatives
0.043 0.957 0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.042 0.957 0.000
M06.9 Rheumatoid arthritis, unspecified
0.000 0.957 0.043
T45.9 Primarily systemic and haematological agent, unspecified
0.042 0.958 0.000
T45.8 Other primarily systemic and haematological agents
0.042 0.958 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.042 0.958 0.000
T45.6 Fibrinolysis-affecting drugs
0.042 0.958 0.000
T45.4 Iron and its compounds
0.042 0.958 0.000
T45.3 Enzymes, not elsewhere classified
0.042 0.958 0.000
T47.4 Other laxatives
0.041 0.958 0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.959 0.041
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.959 0.040
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.040 0.960 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.040 0.960 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.040 0.960 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.040 0.960 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.040 0.960 0.000
T44.0 Anticholinesterase agents
0.040 0.960 0.000
T36.0 Penicillins
0.040 0.960 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.040 0.960 0.000
T36.8 Other systemic antibiotics
0.040 0.960 0.000
T46.5 Other antihypertensive drugs, not elsewhere classified
0.040 0.960 0.000
T45.5 Anticoagulants
0.039 0.961 0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.961 0.039
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.039 0.961 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.039 0.961 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.039 0.961 0.000
T47.7 Emetics
0.039 0.961 0.000
T47.6 Antidiarrhoeal drugs
0.039 0.961 0.000
T47.5 Digestants
0.039 0.961 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2026 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.